Quick Answer
REGENXBIO Inc. reported Total Assets of $453.03 million for fiscal year 2025.
REGENXBIO Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $453.03M | -2.8% |
| 2024 | $465.99M | -18.8% |
| 2023 | $573.97M | -31.1% |
| 2022 | $833.27M | -25.2% |
| 2021 | $1.11B | +57.3% |
| 2020 | $708.16M | +42.2% |
| 2019 | $497.91M | -8.4% |
| 2018 | $543.81M | +173.7% |
| 2017 | $198.68M | +15.0% |
| 2016 | $172.73M | -22.0% |
| 2015 | $221.38M | +6241.4% |
| 2014 | $3.49M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $525.20M | +1.2% | -9.6% |
| June 30, 2025 | $581.03M | +2.0% | +18.4% |
| March 31, 2025 | $490.93M | -22.0% | +5.4% |
| December 31, 2024 | $465.99M | -18.8% | -10.2% |
| September 30, 2024 | $519.11M | -18.1% | -8.8% |
| June 30, 2024 | $569.38M | -16.6% | -9.5% |
| March 31, 2024 | $629.22M | -15.9% | +9.6% |
| December 31, 2023 | $573.97M | -31.1% | -9.4% |
- REGENXBIO Inc. showed a decrease of -2.8% in Total Assets compared to the prior fiscal year.
- Over the 2014–2025 period, REGENXBIO Inc.’s total assets has grown by 12877.1% (from $3.49 million to $453.03 million).
- The most recent figure is from REGENXBIO Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: